Strategies for robust, accurate, and generalizable benchmarking of drug discovery platforms is a research paper published in Bioinformatics (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health Director’s Pioneer
Grant: DP1OD006779
ASPIRE Reduction-to-Practice
Grant: UL1TR001412
National Library of Medicine T15 Award and R25
Grant: T15LM012495
National Library of Medicine T15 Award and R25
Grant: R25LM014213
National Institute of Standards of Technology
Grant: 60NANB22D168
National Institute on Drug Abuse Mentored Research Scientist Development
Grant: K01DA056690
National Institutes of Health
Grant: 1K01DA056690-01
A translational bioinformatics approach to elucidate and mitigate polypharmacy induced adverse drug reactions
National Institutes of Health
Grant: 5DP1OD006779-02
NOVEL PARADIGMS FOR DRUG DISCOVERY: COMPUTATIONAL MULTITARGET SCREENING
National Institutes of Health
Grant: 3UL1TR001412-08S3
Buffalo Clinical and Translational Research Center
National Institutes of Health
Grant: 3T15LM012495-05S1
National Library of Medicine Conference 2022
National Institutes of Health
Grant: 5R25LM014213-02
Buffalo Research Innovation in Genomic and Healthcare Technology (BRIGHT) Short-Term Training and Education
Department of Biomedical Informatics at the University
National Center for Advancing Translational Sciences Clinical and Translational Sciences
ASPIRE Design Challenge
FWCI
0.00
Citation Percentile
0.3%
Fields of Study
MeSH Terms
Keywords